Italy's Lombardy region prepares Eruo303m healthcare and R&D modernisation:
This article was originally published in Clinica
Italy's Lombardy region is preparing to launch a Euro303m ($447m) healthcare modernisation programme, after completing a co-investment agreement with the national government. The programme comprises 48 specific activities, with the aim of meeting 10 objectives. These include: the development of a four-tier network of healthcare facilities; the modernisation of all facilities up to health service standards (set out in 1998 legislation); establishing a hospital inpatient capacity of 4.5 beds per 1,000 populations; and the development of the region's biomedical technology R&D network.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.